Tees Esk and Wear Valleys NHS Foundation Trust
York, United Kingdom
NCT Number: NCT04291547
The primary aim of this non-randomised feasibility study is to 1) examine the acceptability of a newly developed computerised Behavioural Activation programme (BALM) in treating young people experiencing low mood/depression and 2) assess the feasibility of undertaking a pilot Randomised Controlled Trial (RCT) of the intervention.
Looking for future studies?
Notify Me11 year–16 year
All sexes
Interventional
Not applicable
York, United Kingdom
Approximately 20% of adolescents will have had at least one depressive episode by the age of 18 making depression one of the leading causes of illness and disability in young people. Although receiving effective treatment is important, as few as 35% of young people seek help, with treatment-related issues (e.g. stigma, negative attitudes about help-seeking, accessibility, reluctance to engage one-to-one with a therapist, etc) outlined as reasons for this. Computerised therapies, which have increased availability and accessibility, reduced stigma and can be delivered in a format attractive to many young people may avoid some of these barriers and provide a more effective treatment option for young people.
Behavioural Activation (BA) - a type of talking therapy focused on increasing liked activities has demonstrated effectiveness in treating depression in adults and, owing to this, is an evidence-based treatment for depression within NICE (2009) guidelines. Despite this, less research has examined its use with young people.
We have developed BALM (Behavioural Activation for Low Mood), an online BA programme designed for use with young people experiencing mild to moderate low mood or depression. The development of BALM was based upon the findings of a systematic review and a series of qualitative interviews and focus groups with young people and healthcare professionals.
Eligible young people will be referred to the programme via healthcare professionals working in local Child and Adolescent Mental Health Services and mental health practitioners based in local secondary schools.
The findings of this research will allow us to refine the intervention and the research methods we employ in preparation for a pilot randomised controlled trial (RCT) of the new treatment.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An online Behavioural Activation programme for young people with mild to moderate low mood/depression. The programme comprises 10 treatment sessions lasting 30 to 45 minutes
Time frame: 4 months
Assessed by examining questionnaire response rates
Time frame: 4 months
Assessed by examining the percentage of those eligible who consented to the study
Time frame: 4 months
Assessed by examining number and reasons for withdrawal
Time frame: 4 months
Assessed by examining session attendance
Time frame: 4 months
Assessed by examining session adherence
Time frame: 4 months
Assessed by examining responses on an evaluation questionnaire comprising 15 short questions
University of York
Other
Computerised Behavioural Activation Programme for the Treatment of Depression in Young People: Feasibility Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06188962
Anxiety, Anxiety Disorders
London, United Kingdom
View Trial DetailsNCT05963581
Behavior, Behavioral Symptoms
Oxford, United Kingdom
View Trial DetailsNCT05627154
Anxiety, Anxiety Disorders
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT05373121
Anxiety, Anxiety Disorder
London, United Kingdom
View Trial Details